Infectious Disease Point of Care Diagnostics Market Size and Growth AnalysisPosted by venkatakiran on October 17th, 2019 Infectious Disease Point of Care Diagnostics Market Size and Growth Rate:
“The Global Infectious Disease Point of Care Diagnostics Market was valued around US$ XX Mn by 2018 and expected to reach around USD 13 Bn by 2025 due to high prevalence of infectious diseases in developing countries”
Infectious Disease Point of Care Diagnostics Market Growth Drivers and Restraints: The global infectious disease point of care diagnostics market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Some of the key factors fostering the market growth include rising preference for home healthcare across the globe, increasing prevalence of infectious diseases, growing healthcare expenditure, high prevalence of infectious diseases in developing countries, emergence of electronic medical records (EMR) usage with point of care (POC) diagnostics and increasing number of initiatives by various governments and government associations. However, stringent and time-consuming regulatory policies are the key factors hindering the market growth Browse More Insights of the report @https://www.precisionbusinessinsights.com/market-reports/global-infectious-disease-point-of-care-diagnostics-market/ Haematology Testing Kits dominate the Global Infectious Disease Point of Care Diagnostics Market Based on product type, global infectious disease point of care diagnostics market is segmented into infectious disease testing kits & reagents, haematology testing kits, urinalysis testing kits and others. Haematology Testing Kits held considerable market growth during estimated period. It is a branch of internal medicine that deals with the physiology, pathology, etiology, diagnosis, treatment, prognosis and prevention of blood-related disorders. Hematologists also focus on lymphatic organs and bone marrow and may diagnose blood count irregularities or platelet irregularities. They are able to treat organs that are fed by blood cells, including the lymph nodes, spleen, thymus and lymphoid tissue. Asia Pacific Leads the Global Infectious Disease Point of Care Diagnostics market
PBI’s global infectious disease point of care diagnostics market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. Asia Pacific accounted for larger revenue share in global infectious disease point of care diagnostics market with considerable CAGR due to increasing awareness about diseases, rising government funding in these countries, large pool of patients and improving healthcare infrastructure. In addition, North America held significant market share during estimated period owing to increasing number of product approvals, and rising government initiatives to support the adoption of POC in this region. Strategic Approvals are the key strategies adopted by market players
Global infectious disease point of care diagnostics market further reveals that the key players increasingly accepting strategies such as approvals of the new products, launch of newer products, recurrent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the regions. For Instance, In 2014, in the cardiovascular space, Spartan Biosciences had received approval from Health Care Canada for its genetic test, Spartan RX CYP2C19 system. Key player’s profiles in the report are Cepheid Inc. (Danaher Corporation) (U.S.), Abbott Laboratories, Inc. (U.S.), F. Hoffmann La Roche Limited (Switzerland), Beckman Coulter, Inc. (U.S.), Siemens AG (Germany), Johnson & Johnson Services, Inc. (U.S.), Instrumentation Laboratory (U.S.), Becton, Dickinson and Company (U.S.), Alere Inc. (U.S.), Nova Biomedical (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Quidel Corporation (U.S.). Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=16259 Detailed Segmentation of Infectious Disease Point of Care Diagnostics Market:
By Product Type o Infectious Disease Testing Kits & Reagents
o Haematology Testing Kits o Urinalysis Testing Kits o Others
By Disease Condition o Bacterial Infections o Fungal Infections o Viral Infections o Cardiovascular Infections o GI Infections o Sexually Transmitted Disease o CNS Infections o Other
By Prescription Mode o Over-The-Counter (OTC) Testing Kits o Prescription-based Testing Kits
By End User o Professional Diagnostic Centres
o Homecare o Others
By Geography o North America o Europe o Asia-Pacific o Latin America o Middle East and Africa (MEA) About Us: Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights. Contact Us: Shreya Paul Senior Business Development Executive Email @ shreya@precisionbusinessinsights.com Call @ +1-866-598-1553 Precision Business Insights Like it? Share it! More by this author |